tripelennamine has been researched along with Dermatomycoses in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Dermatomycoses: Superficial infections of the skin or its appendages by any of various fungi.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DREWS, L | 1 |
| Sheklakov, ND | 1 |
| Stepanova, ZhV | 1 |
| Rukavishnikova, VM | 1 |
| Shirshikova, IuI | 1 |
2 other studies available for tripelennamine and Dermatomycoses
| Article | Year |
|---|---|
[The treatment of dermatomycoses].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Dermatomycoses; Halogens; Hydrocarbons, Halogenate | 1955 |
[Antimycotic activity of various foreign drugs for external application].
Topics: Administration, Topical; Amines; Antifungal Agents; Boric Acids; Clioquinol; Czechoslovakia; Dermato | 1977 |